224 related articles for article (PubMed ID: 31115501)
1. MicroRNA-625 inhibits the progression of non‑small cell lung cancer by directly targeting HOXB5 and deactivating the Wnt/β-catenin pathway.
Tan X; Jiang L; Wu X; Feng W; Lin Q
Int J Mol Med; 2019 Jul; 44(1):346-356. PubMed ID: 31115501
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Homeobox B5 (HOXB5) Inhibits Cell Proliferation, Migration, and Invasion in Non-Small Cell Lung Cancer Cells Through Inactivation of the Wnt/β-Catenin Pathway.
Zhang B; Li N; Zhang H
Oncol Res; 2018 Jan; 26(1):37-44. PubMed ID: 28337958
[TBL] [Abstract][Full Text] [Related]
3. miR‑139‑5p enhances cisplatin sensitivity in non‑small cell lung cancer cells by inhibiting cell proliferation and promoting apoptosis via the targeting of Homeobox protein Hox‑B2.
Du H; Bao Y; Liu C; Zhong A; Niu Y; Tang X
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300085
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑103 modulates tumor progression by targeting KLF7 in non‑small cell lung cancer.
Li K; Yuan C
Int J Mol Med; 2020 Sep; 46(3):1013-1028. PubMed ID: 32582959
[TBL] [Abstract][Full Text] [Related]
5. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of long intergenic non-coding RNA LINC00326 inhibits non-small cell lung carcinoma progression by blocking Wnt/β-catenin pathway through modulating the miR-657/dickkopf WNT signaling pathway inhibitor 2 axis.
Zhang Y; Yuan J; Guo M; Xiang R; Xie T; Zhuang X; Dai W; Li Q; Lai Q
Biol Direct; 2023 Feb; 18(1):3. PubMed ID: 36747258
[TBL] [Abstract][Full Text] [Related]
7. Nucleolar and spindle‑associated protein 1 promotes non‑small cell lung cancer progression and serves as an effector of myocyte enhancer factor 2D.
Ling B; Wei P; Xiao J; Cen B; Wei H; Feng X; Ye G; Li S; Zhang Z; Liang W; Huang S; Huang W
Oncol Rep; 2021 Mar; 45(3):1044-1058. PubMed ID: 33650655
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑433 reduces cell proliferation and invasion in non‑small cell lung cancer via directly targeting E2F transcription factor 3.
Liu N; Liu Z; Zhang W; Li Y; Cao J; Yang H; Li X
Mol Med Rep; 2018 Jul; 18(1):1155-1164. PubMed ID: 29767254
[TBL] [Abstract][Full Text] [Related]
9. MYPT1, regulated by miR-19b-3p inhibits the progression of non-small cell lung cancer via inhibiting the activation of wnt/β-catenin signaling.
Wang Y; Wang L; Guo J; Zuo S; Wang Z; Hua S
Life Sci; 2021 Aug; 278():119573. PubMed ID: 33964297
[TBL] [Abstract][Full Text] [Related]
10. miR‑192‑5p upregulation mediates the suppression of curcumin in human NSCLC cell proliferation, migration and invasion by targeting c‑Myc and inactivating the Wnt/β‑catenin signaling pathway.
Pan Y; Sun Y; Liu Z; Zhang C
Mol Med Rep; 2020 Aug; 22(2):1594-1604. PubMed ID: 32626956
[TBL] [Abstract][Full Text] [Related]
11. ΜicroRNA‑421 promotes the progression of non‑small cell lung cancer by targeting HOPX and regulating the Wnt/β‑catenin signaling pathway.
Liang H; Wang C; Gao K; Li J; Jia R
Mol Med Rep; 2019 Jul; 20(1):151-161. PubMed ID: 31115507
[TBL] [Abstract][Full Text] [Related]
12. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-454 inhibits non‑small cell lung cancer cells growth and metastasis via targeting signal transducer and activator of transcription-3.
Liu S; Ge X; Su L; Zhang A; Mou X
Mol Med Rep; 2018 Mar; 17(3):3979-3986. PubMed ID: 29286124
[TBL] [Abstract][Full Text] [Related]
14. Long non‑coding RNA MEG3 inhibits cell migration and invasion of non‑small cell lung cancer cells by regulating the miR‑21‑5p/PTEN axis.
Lv D; Bi Q; Li Y; Deng J; Wu N; Hao S; Zhao M
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495842
[TBL] [Abstract][Full Text] [Related]
15. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
Zhao M; Ma W; Ma C
Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
[TBL] [Abstract][Full Text] [Related]
16. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
Zhang Z; Yang Y; Zhang X
Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
[TBL] [Abstract][Full Text] [Related]
17. Upregulated microRNA‑671‑3p promotes tumor progression by suppressing forkhead box P2 expression in non‑small‑cell lung cancer.
Li ZY; Zhang ZZ; Bi H; Zhang QD; Zhang SJ; Zhou L; Zhu XQ; Zhou J
Mol Med Rep; 2019 Oct; 20(4):3149-3159. PubMed ID: 31432170
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-29c inhibits proliferation and promotes apoptosis in non-small cell lung cancer cells by targeting VEGFA.
Zhan S; Wang C; Yin F
Mol Med Rep; 2018 May; 17(5):6705-6710. PubMed ID: 29512752
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-520a Suppresses Pathogenesis and Progression of Non-Small-Cell Lung Cancer through Targeting the RRM2/Wnt Axis.
Xie Y; Xue C; Guo S; Yang L
Anal Cell Pathol (Amst); 2021; 2021():9652420. PubMed ID: 33859925
[TBL] [Abstract][Full Text] [Related]
20. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
Shao N; Song L; Sun X
Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]